AMZN
Amazon.com, Inc.
AMZN has the edge over CRWS overall, supported by stronger modeled upside and lower modeled downside.
CRWS
Crown Crafts, Inc.
CRWS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CRWS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CRWS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
CRWS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.2x | $2.43 | — |
| Cheap | 7.2x | $3.39 | +39% |
| Fair | 9.9x | $4.65 | +91% |
| Expensive | 12x | $5.59 | +130% |
Historical ranges are pointers, not guarantees.
CRWS has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CRWS Forward outlook
There aren't enough analyst estimates for CRWS to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CRWS on earnings, with more consistent year-over-year improvement.
CRWS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.47 | +$1.41 |
| Q2 2026 | $0.46 | +$1.43 |
| Q1 2026 | $0.17 | +$1.07 |
| Q4 2025 | -$0.89 | -487% |
| Q3 2025 | -$0.94 | -403% |
| Q2 2025 | -$0.97 | -337% |
| Q1 2025 | -$0.90 | -288% |
| Q4 2024 | $0.23 | -52% |
CRWS has returned to profit: it earned $0.47 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CRWS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CRWS on profitability, with a higher operating margin.
CRWS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19M | -20% |
| Q2 2026 | $16.8M | +8.3% |
| Q1 2026 | $22.4M | -3.7% |
| Q4 2025 | $20.7M | -11% |
| Q3 2025 | $23.7M | -3.1% |
| Q2 2025 | $15.5M | -4.5% |
| Q1 2025 | $23.2M | +2.9% |
| Q4 2024 | $23.4M | -1.9% |
CRWS's revenue has slid since its 2022 peak: $19M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.4 points |
| Q2 2026 | 17% | +24 points |
| Q1 2026 | 2.4% | +63 points |
| Q4 2025 | -0.5% | -7.8 points |
| Q3 2025 | 7.9% | +1.7 points |
| Q2 2025 | -7.8% | -5.9 points |
| Q1 2025 | -61% | -67 points |
| Q4 2024 | 7.3% | -2.5 points |
CRWS's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CRWS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.4M | +$6.4M |
| Q2 2026 | $5.4M | +3.7% |
| Q1 2026 | $926K | -65% |
| Q4 2025 | $2.3M | +$2.6M |
| Q3 2025 | -$1M | +$155K |
| Q2 2025 | $5.2M | -33% |
| Q1 2025 | $2.6M | -8.5% |
| Q4 2024 | -$220K | +$451K |
CRWS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over CRWS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CRWS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +55K shares |
| 1 year | +1.7% | +181K shares |
| 3 years | +6% | +614K shares |
| 5 years | +7.1% | +721K shares |
| Available history | +6.3% | +638K shares |
CRWS has 11M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $18,000 |
| Q4 2022 | — |
| Q3 2022 | $27,000 |
| Q2 2022 | $162,000 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over CRWS on leverage, with a lower net debt burden relative to earnings.
CRWS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 5.3x | High |
| Q4 2024 | 3.5x | Elevated |
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 0.1x | Very low |
| Q1 2024 | 0.9x | Very low |
| Q4 2023 | 1.2x | Healthy |
CRWS's net debt is less than a year of its operating earnings (EBITDA), down from 3.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CRWS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.8 | Neutral |
| Stochastic | 18.4 | Oversold |
CRWS's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CRWS PE vs Consumer Cyclical Sector
| Metric | CRWS | Sector median | Relative |
|---|---|---|---|
| PE | 5.2x | 18x | 71% below |
| PE % | 0 | 47 | 47 pts below |
CRWS has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CRWS on trend strength, trading above more of its moving averages.
CRWS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 0.4% below |
| 20 week MA | $2.70 | 10% below |
| 50 week MA | $2.76 | 12% below |
| 100 week MA | $3.05 | 20% below |
| 200 week MA | $4.06 | 40% below |
CRWS is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CRWS on returns for 2026, with the stronger performance.
CRWS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.10 | $7.15 | +17% |
| 2021 | $7.15 | $7.04 | -1.5% |
| 2022 | $7.04 | $5.30 | -25% |
| 2023 | $5.30 | $4.96 | -6.4% |
| 2024 | $4.96 | $4.51 | -9.1% |
| 2025 | $4.51 | $2.67 | -41% |
| 2026 YTD | $2.67 | $2.43 | -9% |
CRWS has finished five years in a row lower, and it's down 9% so far in 2026.